Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 185.28 ($2.46) and traded as high as GBX 203.50 ($2.70). Spire Healthcare Group shares last traded at GBX 198.80 ($2.64), with a volume of 664,310 shares traded.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Spire Healthcare Group from GBX 320 ($4.25) to GBX 300 ($3.99) and set a "buy" rating on the stock in a research note on Thursday, March 6th.
Get Our Latest Stock Analysis on Spire Healthcare Group
Spire Healthcare Group Price Performance
The stock has a market cap of £791.89 million, a PE ratio of 28.07, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The company's fifty day moving average is GBX 183.77 and its 200 day moving average is GBX 210.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, sell-side analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.
Spire Healthcare Group Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Friday, June 20th. Stockholders of record on Thursday, May 22nd will be paid a GBX 2.30 ($0.03) dividend. The ex-dividend date is Thursday, May 22nd. This represents a dividend yield of 1.29%. This is a boost from Spire Healthcare Group's previous dividend of $2.10. Spire Healthcare Group's payout ratio is currently 42.70%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
